₹4469.90▲₹139.30(+3.14%)
EOD close · 3 Jul 2026
breakdownaccumulation +28Quiet accumulation · 1d
Price is under pressure — 24% off its 52-week high — but delivery data shows buyers quietly stepping in. Weak chart, strong hands.
52W low ₹4361.0052W high ₹5890.00
Now at 7% of its 52-week range
Long-term returns
1Y
-20.9%
3Y
+20.8%
5Y
-20.0%
10Y
+140.5%
Phase indicator
breakdown-24.1% from 52w high
Below 200-day MA — long-term trend negative.
1M
+2.4%
3M
-6.3%
1Y
-20.9%
Delivery conviction
accumulationscore +28
Delivery vs 20-day avg1.37x
Quiet accumulation active for 1 consecutive day. See full screener
Lifetime story
Pfizer is up 1399.7% from its lifetime low of ₹298.05 on 31 Mar 2003. ₹10,000 invested then would be worth ₹1,49,971 today (12.3% CAGR over 23.3 years). Lifetime high of ₹6452.85 was set on 2 Sept 2024 (currently -30.7% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
41% cheaper than industry(Industry P/E 49.5)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 28.98 | 0.00 |
| P/B | 4.99 | — |
| Price / Cash flowsubs material | 26.84 | 0.00 |
| Dividend yield | 1.64% | 1.64% |
| Book value / share | 918.71 ₹ | — |
| EPS (TTM)subs material | 157.92 ₹ | 0.00 ₹ |
Market cap
₹20.9K Cr
52W high
₹5890.00
8 Jul 2025
52W low
₹4361.00
29 Jun 2026
Returns ladder
1W
+2.5%
1M
+2.4%
3M
-6.3%
6M
-6.3%
YTD
-8.1%
1Y
-20.9%
3Y
+20.8%
5Y
-20.0%
10Y
+140.5%
Since listing
+781.0%